Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors

Microtubules are linear polymers of α - and β -tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 1999-05, Vol.96 (10), p.5686-5691
Hauptverfasser: Shan, Bei, Medina, Julio C., Santha, Edit, Frankmoelle, Walter P., Ting-C. Chou, Learned, Robert M., Narbut, Mathew R., Stott, Dean, Wu, Pengguang, Jaen, Juan C., Rosen, Terry, Pieter B. M. W. M. Timmermans, Beckmann, Holger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5691
container_issue 10
container_start_page 5686
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 96
creator Shan, Bei
Medina, Julio C.
Santha, Edit
Frankmoelle, Walter P.
Ting-C. Chou
Learned, Robert M.
Narbut, Mathew R.
Stott, Dean
Wu, Pengguang
Jaen, Juan C.
Rosen, Terry
Pieter B. M. W. M. Timmermans
Beckmann, Holger
description Microtubules are linear polymers of α - and β -tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the β 1, β 2, and β 4 isotypes of β -tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.
doi_str_mv 10.1073/pnas.96.10.5686
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69745562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48178</jstor_id><sourcerecordid>48178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-2ab8a290c11e486849182cb93f143b9a8545bfe049ae9da40b403fa451bdd723</originalsourceid><addsrcrecordid>eNqFkt2KEzEUx4Mobl29FryQ4IXe7HTzOZPA3pSyfsCKoL0PmZlMNyWd1Eky2ifxPXwQn8kMrWsVwatwOL_fPyfhAPAUozlGFb3c9TrMZZmLOS9FeQ_MMJK4KJlE98EMIVIVghF2Bh6FsEEISS7QQ3CGEcVCMj4D3z4ZZ5poR3MBl37UzvQRvvet7Wyjo_U99B388R0Wq1QnZ3v40QTbJgOX-1AQKmG9hytMBSqrC6h7uOijjWnrB7hYT1FfbLyFWRvt6OF1N6U2e6jX2vYhX5RctO2Q1sUUG6LOxmqyw2PwoNMumCfH8xysXl-vlm-Lmw9v3i0XN0XDCY4F0bXQRKIGY8NEKZjEgjS1pB1mtJZacMbrziAmtZGtZqhmiHaacVy3bUXoObg6xO5SvTVtk0cetFO7wW71sFdeW_Vnp7e3au1HRbAkOOsvj_rgPycTotra0BjndG98CqqUFeO8JP8FcUW5oIxm8MVf4Manoc9foAjClHEheYYuD1Az-BAG090NjJGa9kJNe6FkOdXTXmTj-ek7T_jDImTg1RGYzF_t3wmqS85F8zWeRP2bzMCzA7AJ0Q93BBO4EvQnaLrWZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201345895</pqid></control><display><type>article</type><title>Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors</title><source>PubMed Central Free</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>JSTOR</source><creator>Shan, Bei ; Medina, Julio C. ; Santha, Edit ; Frankmoelle, Walter P. ; Ting-C. Chou ; Learned, Robert M. ; Narbut, Mathew R. ; Stott, Dean ; Wu, Pengguang ; Jaen, Juan C. ; Rosen, Terry ; Pieter B. M. W. M. Timmermans ; Beckmann, Holger</creator><creatorcontrib>Shan, Bei ; Medina, Julio C. ; Santha, Edit ; Frankmoelle, Walter P. ; Ting-C. Chou ; Learned, Robert M. ; Narbut, Mathew R. ; Stott, Dean ; Wu, Pengguang ; Jaen, Juan C. ; Rosen, Terry ; Pieter B. M. W. M. Timmermans ; Beckmann, Holger</creatorcontrib><description>Microtubules are linear polymers of α - and β -tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the β 1, β 2, and β 4 isotypes of β -tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.96.10.5686</identifier><identifier>PMID: 10318945</identifier><language>eng</language><publisher>United States: National Academy of Sciences of the United States of America</publisher><subject>Actinomycin ; Animals ; Antineoplastic Agents - pharmacology ; Apoptosis - drug effects ; b-tubulin ; Biological Sciences ; Cell Cycle - drug effects ; Cell growth ; Cell lines ; Cellular biology ; Cysteine - chemistry ; Cytoskeleton - drug effects ; Diploidy ; Drug resistance ; Drug Resistance, Multiple ; Heterologous transplantation ; Humans ; Isotypes ; Leukemia, Lymphoid - drug therapy ; Medical research ; Mice ; Mice, Nude ; Microtubules ; Microtubules - metabolism ; Molecular Structure ; Neoplasm Transplantation ; Paclitaxel - pharmacology ; Polymerization ; Protein Binding ; Sulfonamides - chemical synthesis ; Sulfonamides - pharmacology ; Tubulin - chemistry ; Tumor cell line ; Tumor Cells, Cultured ; Tumors ; Vinblastine - pharmacology</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 1999-05, Vol.96 (10), p.5686-5691</ispartof><rights>Copyright 1993-1999 The National Academy of Sciences of the United States of America</rights><rights>Copyright National Academy of Sciences May 11, 1999</rights><rights>Copyright © 1999, The National Academy of Sciences 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-2ab8a290c11e486849182cb93f143b9a8545bfe049ae9da40b403fa451bdd723</citedby><cites>FETCH-LOGICAL-c521t-2ab8a290c11e486849182cb93f143b9a8545bfe049ae9da40b403fa451bdd723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/96/10.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48178$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48178$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27924,27925,53791,53793,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10318945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shan, Bei</creatorcontrib><creatorcontrib>Medina, Julio C.</creatorcontrib><creatorcontrib>Santha, Edit</creatorcontrib><creatorcontrib>Frankmoelle, Walter P.</creatorcontrib><creatorcontrib>Ting-C. Chou</creatorcontrib><creatorcontrib>Learned, Robert M.</creatorcontrib><creatorcontrib>Narbut, Mathew R.</creatorcontrib><creatorcontrib>Stott, Dean</creatorcontrib><creatorcontrib>Wu, Pengguang</creatorcontrib><creatorcontrib>Jaen, Juan C.</creatorcontrib><creatorcontrib>Rosen, Terry</creatorcontrib><creatorcontrib>Pieter B. M. W. M. Timmermans</creatorcontrib><creatorcontrib>Beckmann, Holger</creatorcontrib><title>Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>Microtubules are linear polymers of α - and β -tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the β 1, β 2, and β 4 isotypes of β -tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.</description><subject>Actinomycin</subject><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>b-tubulin</subject><subject>Biological Sciences</subject><subject>Cell Cycle - drug effects</subject><subject>Cell growth</subject><subject>Cell lines</subject><subject>Cellular biology</subject><subject>Cysteine - chemistry</subject><subject>Cytoskeleton - drug effects</subject><subject>Diploidy</subject><subject>Drug resistance</subject><subject>Drug Resistance, Multiple</subject><subject>Heterologous transplantation</subject><subject>Humans</subject><subject>Isotypes</subject><subject>Leukemia, Lymphoid - drug therapy</subject><subject>Medical research</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Microtubules</subject><subject>Microtubules - metabolism</subject><subject>Molecular Structure</subject><subject>Neoplasm Transplantation</subject><subject>Paclitaxel - pharmacology</subject><subject>Polymerization</subject><subject>Protein Binding</subject><subject>Sulfonamides - chemical synthesis</subject><subject>Sulfonamides - pharmacology</subject><subject>Tubulin - chemistry</subject><subject>Tumor cell line</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Vinblastine - pharmacology</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkt2KEzEUx4Mobl29FryQ4IXe7HTzOZPA3pSyfsCKoL0PmZlMNyWd1Eky2ifxPXwQn8kMrWsVwatwOL_fPyfhAPAUozlGFb3c9TrMZZmLOS9FeQ_MMJK4KJlE98EMIVIVghF2Bh6FsEEISS7QQ3CGEcVCMj4D3z4ZZ5poR3MBl37UzvQRvvet7Wyjo_U99B388R0Wq1QnZ3v40QTbJgOX-1AQKmG9hytMBSqrC6h7uOijjWnrB7hYT1FfbLyFWRvt6OF1N6U2e6jX2vYhX5RctO2Q1sUUG6LOxmqyw2PwoNMumCfH8xysXl-vlm-Lmw9v3i0XN0XDCY4F0bXQRKIGY8NEKZjEgjS1pB1mtJZacMbrziAmtZGtZqhmiHaacVy3bUXoObg6xO5SvTVtk0cetFO7wW71sFdeW_Vnp7e3au1HRbAkOOsvj_rgPycTotra0BjndG98CqqUFeO8JP8FcUW5oIxm8MVf4Manoc9foAjClHEheYYuD1Az-BAG090NjJGa9kJNe6FkOdXTXmTj-ek7T_jDImTg1RGYzF_t3wmqS85F8zWeRP2bzMCzA7AJ0Q93BBO4EvQnaLrWZA</recordid><startdate>19990511</startdate><enddate>19990511</enddate><creator>Shan, Bei</creator><creator>Medina, Julio C.</creator><creator>Santha, Edit</creator><creator>Frankmoelle, Walter P.</creator><creator>Ting-C. Chou</creator><creator>Learned, Robert M.</creator><creator>Narbut, Mathew R.</creator><creator>Stott, Dean</creator><creator>Wu, Pengguang</creator><creator>Jaen, Juan C.</creator><creator>Rosen, Terry</creator><creator>Pieter B. M. W. M. Timmermans</creator><creator>Beckmann, Holger</creator><general>National Academy of Sciences of the United States of America</general><general>National Acad Sciences</general><general>National Academy of Sciences</general><general>The National Academy of Sciences</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990511</creationdate><title>Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors</title><author>Shan, Bei ; Medina, Julio C. ; Santha, Edit ; Frankmoelle, Walter P. ; Ting-C. Chou ; Learned, Robert M. ; Narbut, Mathew R. ; Stott, Dean ; Wu, Pengguang ; Jaen, Juan C. ; Rosen, Terry ; Pieter B. M. W. M. Timmermans ; Beckmann, Holger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-2ab8a290c11e486849182cb93f143b9a8545bfe049ae9da40b403fa451bdd723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Actinomycin</topic><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>b-tubulin</topic><topic>Biological Sciences</topic><topic>Cell Cycle - drug effects</topic><topic>Cell growth</topic><topic>Cell lines</topic><topic>Cellular biology</topic><topic>Cysteine - chemistry</topic><topic>Cytoskeleton - drug effects</topic><topic>Diploidy</topic><topic>Drug resistance</topic><topic>Drug Resistance, Multiple</topic><topic>Heterologous transplantation</topic><topic>Humans</topic><topic>Isotypes</topic><topic>Leukemia, Lymphoid - drug therapy</topic><topic>Medical research</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Microtubules</topic><topic>Microtubules - metabolism</topic><topic>Molecular Structure</topic><topic>Neoplasm Transplantation</topic><topic>Paclitaxel - pharmacology</topic><topic>Polymerization</topic><topic>Protein Binding</topic><topic>Sulfonamides - chemical synthesis</topic><topic>Sulfonamides - pharmacology</topic><topic>Tubulin - chemistry</topic><topic>Tumor cell line</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Vinblastine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shan, Bei</creatorcontrib><creatorcontrib>Medina, Julio C.</creatorcontrib><creatorcontrib>Santha, Edit</creatorcontrib><creatorcontrib>Frankmoelle, Walter P.</creatorcontrib><creatorcontrib>Ting-C. Chou</creatorcontrib><creatorcontrib>Learned, Robert M.</creatorcontrib><creatorcontrib>Narbut, Mathew R.</creatorcontrib><creatorcontrib>Stott, Dean</creatorcontrib><creatorcontrib>Wu, Pengguang</creatorcontrib><creatorcontrib>Jaen, Juan C.</creatorcontrib><creatorcontrib>Rosen, Terry</creatorcontrib><creatorcontrib>Pieter B. M. W. M. Timmermans</creatorcontrib><creatorcontrib>Beckmann, Holger</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shan, Bei</au><au>Medina, Julio C.</au><au>Santha, Edit</au><au>Frankmoelle, Walter P.</au><au>Ting-C. Chou</au><au>Learned, Robert M.</au><au>Narbut, Mathew R.</au><au>Stott, Dean</au><au>Wu, Pengguang</au><au>Jaen, Juan C.</au><au>Rosen, Terry</au><au>Pieter B. M. W. M. Timmermans</au><au>Beckmann, Holger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>1999-05-11</date><risdate>1999</risdate><volume>96</volume><issue>10</issue><spage>5686</spage><epage>5691</epage><pages>5686-5691</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Microtubules are linear polymers of α - and β -tubulin heterodimers and are the major constituents of mitotic spindles, which are essential for the separation of chromosomes during mitosis. Here we describe a synthetic compound, 2-fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene (T138067), which covalently and selectively modifies the β 1, β 2, and β 4 isotypes of β -tubulin at a conserved cysteine residue, thereby disrupting microtubule polymerization. Cells exposed to T138067 become altered in shape, indicating a collapse of the cytoskeleton, and show an increase in chromosomal ploidy. Subsequently, these cells undergo apoptosis. Furthermore, T138067 exhibits cytotoxicity against tumor cell lines that exhibit substantial resistance to vinblastine, paclitaxel, doxorubicin, and actinomycin D. T138067 is also equally efficacious in inhibiting the growth of sensitive and multidrug-resistant human tumor xenografts in athymic nude mice. These observations suggest that T138067 may be clinically useful for the treatment of multidrug-resistant tumors.</abstract><cop>United States</cop><pub>National Academy of Sciences of the United States of America</pub><pmid>10318945</pmid><doi>10.1073/pnas.96.10.5686</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 1999-05, Vol.96 (10), p.5686-5691
issn 0027-8424
1091-6490
language eng
recordid cdi_proquest_miscellaneous_69745562
source PubMed Central Free; MEDLINE; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; JSTOR
subjects Actinomycin
Animals
Antineoplastic Agents - pharmacology
Apoptosis - drug effects
b-tubulin
Biological Sciences
Cell Cycle - drug effects
Cell growth
Cell lines
Cellular biology
Cysteine - chemistry
Cytoskeleton - drug effects
Diploidy
Drug resistance
Drug Resistance, Multiple
Heterologous transplantation
Humans
Isotypes
Leukemia, Lymphoid - drug therapy
Medical research
Mice
Mice, Nude
Microtubules
Microtubules - metabolism
Molecular Structure
Neoplasm Transplantation
Paclitaxel - pharmacology
Polymerization
Protein Binding
Sulfonamides - chemical synthesis
Sulfonamides - pharmacology
Tubulin - chemistry
Tumor cell line
Tumor Cells, Cultured
Tumors
Vinblastine - pharmacology
title Selective, Covalent Modification of β -Tubulin Residue Cys-239 by T138067, an Antitumor Agent with in vivo Efficacy against Multidrug-Resistant Tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T17%3A12%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selective,%20Covalent%20Modification%20of%20%CE%B2%20-Tubulin%20Residue%20Cys-239%20by%20T138067,%20an%20Antitumor%20Agent%20with%20in%20vivo%20Efficacy%20against%20Multidrug-Resistant%20Tumors&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Shan,%20Bei&rft.date=1999-05-11&rft.volume=96&rft.issue=10&rft.spage=5686&rft.epage=5691&rft.pages=5686-5691&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.96.10.5686&rft_dat=%3Cjstor_proqu%3E48178%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201345895&rft_id=info:pmid/10318945&rft_jstor_id=48178&rfr_iscdi=true